Copaxone for Multiple Sclerosis

Links shared publicly online about this topic

Multiple Sclerosis Resource Centre COPAXONE

msrc.co.uk — “The home site of the Multiple Sclerosis Resource Centre, Multiple Sclerosis, Multiple Sclerosis Resource Centre, MSRC, Telephone Counselling Service, 24hour, MS, Health, Disabled, Myelin, MRI, Physically Disabled, Service, MS Drugs, MS News, Beta Interferon, Disability, MS Research, Best Bet Diet, BBD, Discussion Boards, Support, immunology, onset symptoms, warning signs, early symptoms, nutrition, symptoms, treatment, diagnosis, history, COPAXONEView full resource at msrc.co.uk

  • View Related
  • Share

Most Recently Shared on June 22, 2010 at 7:40 am By:

georgejelinek George Jelinek Doctor, Emergency Physician, and Physician

Copaxone twice weekly seems to work: one wonders whether Copaxone might be even more helpful if given less frequently http://bit.ly/cUWIVK

2 years ago...

Multiple Sclerosis - Taking Copaxone to Treat My MS

healthcentral.com — “The decision to use or not use a disease-modifying treatment is a personal one between yourself, your family, and your doctor. Some patients decide to jump in and get started and others wait to see how their MS is going to progress.View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on March 19, 2009 at 8:52 pm By:

LisaEmrich Lisa Emrich Patient Expert

Taking Copaxone to Treat My MS: The decision to use or not use a disease-modifying treatment is a personal one b.. http://tinyurl.com/cayl3b

3 years ago...

Teva Announces Copaxone(R) Reaches One Million Patient Years Of Experience In The Treatment Of Multiple Sclerosis

medicalnewstoday.com — “Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced today that Copaxone® (glatiramer acetate injection), has now achieved one million patient years of experience in the treatment ofView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 14, 2010 at 4:07 am By:

medical_tweets medical_tweets Health News

Teva Announces Copaxone(R) Reaches One Million Patient Years Of Experience In The Treatment Of Multiple Sclerosis Teva .. http://dld.bz/ajej

2 years ago...

Long-Term Study With COPAXONE(R) Indicated Protective Effect On Brain Tissue In Multiple Sclerosis Patients

medicalnewstoday.com — “New data presented provided evidence that long-term treatment with COPAXONE® (glatiramer acetate injection) may offer sustained protection from neuronal/axonal injury. This protective effect wView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 30, 2009 at 1:36 pm By:

LisaEmrich Lisa Emrich Patient Expert

MedNewsToday: Long-Term Study With COPAXONE(R) Indicated Protective Effect On Brain Tissue In Multi.. http://tinyurl.com/czat3v

3 years ago...

Brass and Ivory: I Chose Copaxone to Treat My MS

brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\View full resource at brassandivory.blogspot.com

  • View Related
  • Share

Most Recently Shared on March 19, 2009 at 10:55 pm By:

LisaEmrich Lisa Emrich Patient Expert

I Chose Copaxone to Treat My MS: The decision to use or not use a disease-modifying treatment is a personal one .. http://tinyurl.com/cg5jqc

3 years ago...

Multiple Sclerosis Head-to-Head Study Comparing TYRABRI To Copaxone And Rebif

medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced enrollment of the first patient in a global Phase IIIb, randomized, rater-blinded, active-controlled study designedView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 26, 2010 at 4:10 pm By:

mnt_clinical MNT Clinical Trials Health News

Multiple Sclerosis Head-to-Head Study Comparing TYRABRI To Copaxone And Rebif http://mnt.to/3ztw #clinicaltrials

2 years ago...

Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone | BNET Pharma Blog | BNET

industry.bnet.com — “Is this a rare case of Teva Pharmaceutical being forced to swallow its own bitter medicine? The world’s largest generic manufacturer, founded onView full resource at industry.bnet.com

  • View Related
  • Share

Most Recently Shared on November 6, 2009 at 10:08 pm By:

Jim_Edwards Jim Edwards Health Communicator

Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone: Is this a rare case of Teva Pharmaceutical... http://bit.ly/2llIYS

3 years ago...

Copaxone gains expanded indication - MPR

empr.com — “The FDA has approved an expanded indication for Copaxone (glatiramer acetate injection, from Teva) to include the treatment of patients who have experienced a first clinical episode and have magnetic resonance imaging (MRI) features consistent with multiple sclerosis (MS).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on March 3, 2009 at 9:23 pm By:

eMPR MPR Medical Publisher

Copaxone gains expanded indication: The FDA has approved an expanded indication for Copaxone (glatiramer acetate.. http://tinyurl.com/agh5sm

3 years ago...

Overcoming Multiple Sclerosis - Multiple Sclerosis, Ms Cure, Early Symptom Multiple Sclerosis

overcomingmultiplesclerosis.org — “Multiple Sclerosis is a chronic disease of the Central Nervous System (CNS) and in most cases results in progressive disability. MS can be a tragic disease, as it usually affects young adults in the prime of their lives, and may even occur in childhood. The CNS is the term used to describe the brain and spinal cord.MS is described as an inflammatory demyelinating condition.View full resource at overcomingmultiplesclerosis.org

  • View Related
  • Share

Most Recently Shared on November 20, 2009 at 3:48 am By:

georgejelinek George Jelinek Doctor, Emergency Physician, and Physician

@mommadeb2 Copaxone very likely to be more effective for longer with less side effects than interferons. See http://bit.ly/gnAqz

3 years ago...

Copaxone market share drops in November - Globes

globes.co.il — “Copaxone market share drops in November - GlobesView full resource at globes.co.il

  • View Related
  • Share

Most Recently Shared on December 19, 2010 at 4:16 pm By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Copaxone market share drops in November: The figures for Novartis AG's newly launched oral multiple sclerosis tr... http://bit.ly/hWPNHS

1 year ago...

Copaxone competitor expecting FDA approval today - Globes

globes.co.il — “Copaxone competitor expecting FDA approval today - GlobesView full resource at globes.co.il

  • View Related
  • Share

Most Recently Shared on September 21, 2010 at 8:04 pm By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Copaxone competitor expecting FDA approval today: Novartis oral multiple sclerosis treatment Gilenia is expected t... http://bit.ly/c7lBZ5

2 years ago...

Multiple Sclerosis - Mediitation for Multiple Sclerosis

healthcentral.com — “Meditation and yoga can be beneficial to those of us with MS. Meditation is a contemplative mental exercise for complete relaxation or awareness.View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on May 19, 2010 at 7:03 pm By:

twitterbo Bo Health Site

Yoga and Meditation for Multiple Sclerosis ... http://dld.bz/ege8

2 years ago...

Multiple Sclerosis - Parenting with Multiple Sclerosis

healthcentral.com — “It isn't supposed to be this way is it? You are the parent and have children to take care of. Yet now you are faced with this disease and you wonder if in time your kids will be taking care of you.View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on December 9, 2009 at 3:31 pm By:

twitterbo Bo Health Site

Parenting with Multiple Sclerosis … http://short.to/zsp5

2 years ago...

Is MS Hereditary? - Multiple Sclerosis

healthcentral.com — “Like many people when first diagnosed with MS, I asked the question, --Will my children get MS?-- I was told no. That was 20 years ago. Is that still the case?View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on March 21, 2011 at 4:45 pm By:

Health_Tips HealthCentral Tips Health Site

Research indicates men with MS are 2x as likely as women with MS to pass it on to their children. http://bit.ly/f9tUbv Is MS hereditary?

1 year ago...

Early Initiation Of Treatment With Copaxone (R) Provides Greater Effects In Delaying Conversion To Clinically Definite MS

medicalnewstoday.com — “Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone®View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 19, 2010 at 5:05 pm By:

mnt_multiplescl MNT Multiple Scl Health News

Early Initiation Of Treatment With Copaxone (R) Provides Greater Effects In Delaying Conversion To Clinically Definite MS http://mnt.to/3Lrz

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390